Oncolytics Biotech Inc. ONC.TO Stock
Oncolytics Biotech Inc. Price Chart
Oncolytics Biotech Inc. ONC.TO Financial and Trading Overview
| Oncolytics Biotech Inc. stock price | 1.54 CAD |
| Previous Close | 2.54 CAD |
| Open | 2.5 CAD |
| Bid | 2.56 CAD x 0 |
| Ask | 2.57 CAD x 0 |
| Day's Range | 2.5 - 2.73 CAD |
| 52 Week Range | 1.14 - 3.1 CAD |
| Volume | 177.81K CAD |
| Avg. Volume | 77.78K CAD |
| Market Cap | 164.08M CAD |
| Beta (5Y Monthly) | 1.647907 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.41 CAD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 7.84 CAD |
ONC.TO Valuation Measures
| Enterprise Value | 133.69M CAD |
| Trailing P/E | N/A |
| Forward P/E | -5.565217 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 6.368159 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -4.905 |
Trading Information
Oncolytics Biotech Inc. Stock Price History
| Beta (5Y Monthly) | 1.647907 |
| 52-Week Change | 98.44% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 3.1 CAD |
| 52 Week Low | 1.14 CAD |
| 50-Day Moving Average | 2.06 CAD |
| 200-Day Moving Average | 2.04 CAD |
ONC.TO Share Statistics
| Avg. Volume (3 month) | 77.78K CAD |
| Avg. Daily Volume (10-Days) | 167.25K CAD |
| Shares Outstanding | 64.09M |
| Float | 63.24M |
| Short Ratio | 0.84 |
| % Held by Insiders | 1.34% |
| % Held by Institutions | 1.47% |
| Shares Short | 79.93K |
| Short % of Float | 0.13% |
| Short % of Shares Outstanding | 0.11% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 105:1000 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -42.85% |
| Return on Equity (ttm) | -80.61% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -27258000 CAD |
| Net Income Avi to Common (ttm) | -24493000 CAD |
| Diluted EPS (ttm) | -0.38 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 29.67M CAD |
| Total Cash Per Share (mrq) | 0.46 CAD |
| Total Debt (mrq) | 567K CAD |
| Total Debt/Equity (mrq) | 2.2 CAD |
| Current Ratio (mrq) | 13.876 |
| Book Value Per Share (mrq) | 0.402 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -24932000 CAD |
| Levered Free Cash Flow (ttm) | -15044658 CAD |
Profile of Oncolytics Biotech Inc.
| Country | Canada |
| State | AB |
| City | Calgary |
| Address | 322 11th Avenue SW |
| ZIP | T2R 0C5 |
| Phone | 403 670 7377 |
| Website | https://www.oncolyticsbiotech.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 29 |
Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. The company is developing pelareorep, an intravenously delivered immunotherapeutic agent, which is in phase 3 clinical trial for the treatment of hormone receptor-positive / human epidermal growth factor 2-negative metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma. Oncolytics Biotech Inc. has a co-development agreement with Merck KGaA and Pfizer Inc. to co-develop pelareorep in combination with paclitaxel and Bavencio, a human anti-PD-L1 antibody for the treatment of hormone receptor-positive/human epidermal growth factor 2-negative metastatic breast cancer. The company was incorporated in 1998 and is headquartered in Calgary, Canada.
Q&A For Oncolytics Biotech Inc. Stock
What is a current ONC.TO stock price?
Oncolytics Biotech Inc. ONC.TO stock price today per share is 1.54 CAD.
How to purchase Oncolytics Biotech Inc. stock?
You can buy ONC.TO shares on the Toronto exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Oncolytics Biotech Inc.?
The stock symbol or ticker of Oncolytics Biotech Inc. is ONC.TO.
Which industry does the Oncolytics Biotech Inc. company belong to?
The Oncolytics Biotech Inc. industry is Biotechnology.
How many shares does Oncolytics Biotech Inc. have in circulation?
The max supply of Oncolytics Biotech Inc. shares is 75.42M.
What is Oncolytics Biotech Inc. Price to Earnings Ratio (PE Ratio)?
Oncolytics Biotech Inc. PE Ratio is now.
What was Oncolytics Biotech Inc. earnings per share over the trailing 12 months (TTM)?
Oncolytics Biotech Inc. EPS is -0.41 CAD over the trailing 12 months.
Which sector does the Oncolytics Biotech Inc. company belong to?
The Oncolytics Biotech Inc. sector is Healthcare.